Sample result
SIINFEKL, an exact peptide
A saved result, shown read-only. Sign in to run your own searches. A new account gets a free 30-day trial.
The search
- Query
- SIINFEKL · 8 lettersSIINFEKL
- Search
- Exact text → Patent proteins
- Set
- Public patent sequences: Patent proteins, snapshot 2026-11-05-c456f6bdba29
- Ran
- 2026-11-12
- Found
- 771 sequences, 2,028 publications, 1,357 families
Exact search reads every stored sequence for this text, so these counts are complete. A letter matches only that letter, and an N in a stored sequence is not a wildcard. The list keeps up to 1,000,000 matches. These results do not establish patentability.
Patents
2,028 publications in 1,357 families match these filters.
-
EP 3662927-A22020-06-10
VACCINE COMPOSITION
NITTO DENKO CORP
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020116636-A2020-06-11
IMMUNOSUPPRESSIVE AGENT
ONO PHARMACEUTICAL CO LTD,TOKUSHIMA UNIVERSITY
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by a shared priority claim, JP 2018-229774.
- WO 2020116636-A2020-06-11
- JP 2024056050-A2024-04-19
- JP 2025186411-A2025-12-23
-
US 10682425-B22020-06-16
Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them
The Regents of the University of California
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10682425-B22020-06-16
- US 11602568-B22023-03-14
-
JP 2020517247-A2020-06-18
A Platform for T Lymphocyte Genome Engineering and In Vivo High-Throughput Screening Thereof
Yale University
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020123444-A12020-06-18
METHODS OF USING CD27 ANTIBODIES AS CONDITIONING TREATMENT FOR ADOPTIVE CELL THERAPY
CELLDEX THERAPEUTICS INC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10688165-B22020-06-23
Medicament for use in a method of inducing or extending a cellular cytotoxic immune response
Bundesrepublik Deutschland letztvertreten durch das Robert-Koch-Institut vertreten durch seinen Prasidenten
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 25 to 32. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 25 SIINFEKL 328 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10688165-B22020-06-23
- US 12090194-B22024-09-17
-
WO 2020127277-A12020-06-25
A PEPTIDE-LOADED MHC-I PRESENTING CELL AND AN IL-2 WITH EXTENDED HALF-LIFE FOR AMPLIFYING A CELLULAR CYTOTOXIC IMMUNE RESPONSE
ROBERT KOCH INST
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10696984-B22020-06-30
Packaging cell for making a pseudotyped lentivirus
CALIFORNIA INSTITUTE OF TECHNOLOGY
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020136060-A12020-07-02
A PEPTIDE-MHC-I-ANTIBODY FUSION PROTEIN FOR THERAPEUTIC USE IN A PATIENT WITH AMPLIFIED IMMUNE RESPONSE
HOFFMANN LA ROCHE
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10702597-B22020-07-07
CHIKV RNA vaccines
ModernaTX, Inc.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 27 to 34. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 27 SIINFEKL 348 of 8 identical, no gaps.
-
US 10703817-B22020-07-07
System for delivery into XCR1 positive cell and uses thereof
BUNDESREPUBLIK DEUTSCHLAND LETZVERTRETEN DURCH DAS ROBERT KOCH-INSTITUT VERTRETEN DURCH SEINEN PRAESIDENTEN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 3676250-A12020-07-08
PEPTIDE CONJUGATES, CONJUGATION PROCESS, AND USES THEREOF
AUCKLAND UNISERVICES LTD
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 24 to 31. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 24 SIINFEKL 318 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- EP 3676250-A12020-07-08
- JP 2020532534-A2020-11-12
-
JP 2020521000-A2020-07-16
Combinations of MHC class Ib molecules and Peptides for Targeted Therapeutic Immunomodulation
Julius-Maximilians-Universitaet Wuezburg,Dr rer nat Valentin Bruttel
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10717982-B22020-07-21
Stabilization of poly(A) sequence encoding DNA sequences
BioNTech RNA Pharmaceuticals GmbH and TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10738355-B22020-08-11
Individualized vaccines for cancer
TRON-Translationale Onkologie an der Universitatsmedizin der Johannes Gutenberg-Universitat Mainz gGmbH and BioNTech RNA Pharmaceuticals GmbH
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 3691693-A12020-08-12
A FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE
UNIV UTAH RES FOUND
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
KR 1020200096800-A2020-08-13
METHODS AND COMPOSITIONS COMPRISING CATIONIC LIPIDS FOR STIMULATING TYPE 1 INTERFERON GENES
PDS BIOTECHNOLOGY CORPORATION
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200096800-A2020-08-13
- JP 2021505606-A2021-02-18
- JP 2026063187-A2026-04-10
-
WO 2020161224-A12020-08-13
TREATMENT INVOLVING CAR-ENGINEERED T CELLS AND CYTOKINES
BIONTECH CELL & GENE THERAPIES GMBH
Query Match 100.0%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 5
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020161224-A12020-08-13
- KR 1020210124236-A2021-10-14
- JP 2022519713-A2022-03-24
- EP 4414033-A22024-08-14
- JP 2025087825-A2025-06-10
-
WO 2020163868-A12020-08-13
GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH AND HUMAN SERVICES
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10744157-B22020-08-18
Anti-MICA antigen binding fragments, fusion molecules, cells which express and methods of using
THE TRUSTEES OF DARTMOUTH COLLEGE
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10744157-B22020-08-18
- US 11857571-B22024-01-02
-
US 10753938-B22020-08-25
Beta-catenin inhibitors in cancer immunotherapy
The University of Chicago
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10759838-B22020-09-01
Myelin oligodendrocyte glycoprotein, myelin basic protein, and proteolipid protein compositions and methods of use
The United States of America, as represented by the Secretary, Department of Health & Human Services
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
KR 1020200104887-A2020-09-04
ARTIFICIAL ANTIGEN PRESENTING CELLS AND METHODS OF USE
RUBIUS THERAPEUTICS, INC
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/610149.
- KR 1020200104887-A2020-09-04
- JP 2021506304-A2021-02-22
- JP 2022191365-A2022-12-27
-
KR 1020200105678-A2020-09-08
TARGETING THE CBM SIGNALOSOME COMPLEX INDUCES REGULATORY T CELLS TO INFLAME THE TUMOR MICROENVIRONMENT
THE GENERAL HOSPITAL CORPORATION
Query Match 100.0%Identity 100.0%Family of 4
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 4
Grouped by a shared priority claim, US 62/611186.
- KR 1020200105678-A2020-09-08
- JP 2021508720-A2021-03-11
- US 11571427-B22023-02-07
- JP 2024028924-A2024-03-05
-
JP 2020528403-A2020-09-24
NON-VIRAL GENE DELIVERY AGENT COMPRISING LIPOPEPTIDE (LP) COMPOUNDS
Monash University
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- JP 2020528403-A2020-09-24
- US 11446393-B22022-09-20
-
US 10792348-B22020-10-06
Enhancing T cell activation using altered MHC-peptide ligands
Mayo Foundation for Medical Education and Research
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10793613-B22020-10-06
Compositions and methods for targeted cytokine delivery
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020204714-A12020-10-08
IMMUNE-STIMULATORY COMPOSITIONS AND USE THEREOF
IMMUNETUNE B V
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 168 to 175. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 168 SIINFEKL 1758 of 8 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020204714-A12020-10-08
- KR 1020220019660-A2022-02-17
- JP 2022529139-A2022-06-17
-
WO 2020206307-A12020-10-08
MULTI-SUBUNIT VACCINES TO ELICIT BOTH MHC- AND CD1-RESTRICTED T CELL RESPONSES
UNIV NORTHWESTERN
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10799568-B22020-10-13
Modified adenoviruses for cancer vaccines development
VALO THERAPEUTICS OY
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10799568-B22020-10-13
- US 11730798-B22023-08-22
-
US 10799579-B22020-10-13
Methods for enhancing antigen-specific immune responses
The Johns Hopkins University
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 258 to 265. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 258 SIINFEKL 2658 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- US 10799579-B22020-10-13
- US 11766478-B22023-09-26
-
KR 1020200120329-A2020-10-21
COMPOSITION FOR DELIVERING OF ANTIGEN
Pukyong National University Industry-University Cooperation Foundation
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- KR 1020200120329-A2020-10-21
- KR 1020210087415-A2021-07-12
-
WO 2020214995-A12020-10-22
ANTI-MERTK ANTIBODIES AND THEIR METHODS OF USE
GENENTECH INC
Query Match 100.0%Identity 100.0%Family of 2
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 2
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020214995-A12020-10-22
- KR 1020220002967-A2022-01-07
-
WO 2020218924-A12020-10-29
METHODS AND COMPOSITIONS FOR ISOTHERMAL DNA AMPLIFICATION
SYNVOLUX IP BV
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by the same title and applicant. No priority claim is on record.
- WO 2020218924-A12020-10-29
- KR 1020220025709-A2022-03-03
- JP 2022530476-A2022-06-29
-
US 10821157-B22020-11-03
Glycotargeting therapeutics
ANOKION SA and ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 257 to 264. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 257 SIINFEKL 2648 of 8 identical, no gaps.
-
WO 2020225569-A12020-11-12
PHENYL-SULFAMOYL.BENZOYC ACIDS AS ERAP1 MODULATORS
GREY WOLF THERAPEUTICS LTD
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
KR 1020200130835-A2020-11-20
INTRACELLULAR DELIVERY OF BIOMOLECULES TO MODIFY IMMUNE RESPONSE
SQZ BIOTECHNOLOGIES COMPANY
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/641987.
- KR 1020200130835-A2020-11-20
- JP 2021517813-A2021-07-29
- JP 2025020210-A2025-02-12
-
US 10842863-B22020-11-24
Vaccine against beta-herpesvirus infection and use thereof
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 259 to 266. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 259 SIINFEKL 2668 of 8 identical, no gaps.
-
JP 2020533997-A2020-11-26
Compositions And Methods For Lyophilization Of Bacteria Or Listeria Strains
Advaxis Inc
Query Match 100.0%Identity 100.0%Family of 3
Best alignment and family
Query 1 to 8, hit 3 to 10. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 3 SIINFEKL 108 of 8 identical, no gaps.
Family of 3
Grouped by a shared priority claim, US 62/560318.
- JP 2020533997-A2020-11-26
- JP 2023096115-A2023-07-06
- JP 2025083415-A2025-05-30
-
US 10849963-B22020-12-01
Medicament for use in a method of inducing or extending a cellular cytotoxic immune response
Bundesrepublik Deutschland letztvertreten durch das Robl Koch-Institut vertreten durch seinen Prasidenten
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 25 to 32. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 25 SIINFEKL 328 of 8 identical, no gaps.
-
EP 3743083-A22020-12-02
SELF-ANTIGEN SPECIFIC T-CELLS AS VACINES FOR AUGMENTING ENGRAFTMENT AND STABILITY OF AUTOLOGOUS TRANSFER
UNIV VANDERBILT
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020239934-A12020-12-03
CD8+ T-CELLS LACKING PLEXINS AND THEIR APPLICATION IN CANCER TREATMENT
VIB VZW
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
WO 2020239945-A12020-12-03
CANCER TREATMENT BY TARGETING PLEXINS IN THE IMMUNE COMPARTMENT
VIB VZW
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
US 10857227-B22020-12-08
Immunostimulatory compositions
ASSISTANCE PUBLIQUE-HOSPITAUX DE PARIS and UNIVERSITE PARIS 13
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 18 to 25. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 18 SIINFEKL 258 of 8 identical, no gaps.
-
US 10859566-B22020-12-08
Treatment methods
GENOCEA BIOSCIENCES, INC.
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 3747456-A12020-12-09
METHOD FOR REGULATING ANTIGEN-SPECIFIC MHC EXPRESSION
UNIV TOHOKU
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
KR 1020200140265-A2020-12-15
CPG AMPHIPHILES AND USES THEREOF
ELICIO THERAPEUTICS, INC
Query Match 100.0%Identity 100.0%Family of 5
Best alignment and family
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
Family of 5
Grouped by a shared priority claim, US 62/637824.
- KR 1020200140265-A2020-12-15
- EP 3758712-A12021-01-06
- JP 2021516991-A2021-07-15
- JP 2024045151-A2024-04-02
- US 12247052-B22025-03-11
-
EP 3755369-A12020-12-30
ONCOLYTIC VIRUSES AS ADJUVANTS
TURNSTONE LP
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
EP 3756648-A12020-12-30
IMPROVED VACCINE FORMULATIONS
IMNATE SARL
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.
-
JP 2021500387-A2021-01-07
MHC Exchange
Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis,Academisch Ziekenhuis Leiden h o d n LUMC
Query Match 100.0%Identity 100.0%
Best alignment
Query 1 to 8, hit 1 to 8. Positions start at 1 and include both ends.
Query 1 SIINFEKL 8 |||||||| Hit 1 SIINFEKL 88 of 8 identical, no gaps.